Yixian Liao

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAN Endonuclease Inhibitors.

Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAN Endonuclease Inhibitors.

Journal: Journal of medicinal chemistry

Published: December 15, 2022

Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.

Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2.

Journal: Journal of medicinal chemistry

Published: December 12, 2022

Corrigendum to 'An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ' [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712].

Corrigendum to 'An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ' [International Journal of Infectious Diseases, Volume 115, 2022, Pages 116-125, ISSN 1201-9712].

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: February 04, 2022

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees.

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 08, 2021

Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease.

Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease.

Journal: European journal of medicinal chemistry

Published: November 25, 2019

An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.

An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.

Journal: Viruses

Published: September 22, 2019

Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.

Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.

Journal: Bioorganic & medicinal chemistry letters

Published: June 25, 2019

Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index.

Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index.

Journal: Bioorganic & medicinal chemistry

Published: June 21, 2019

Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.

Incorporation of privileged structures into 3-O-β-chacotriosyl ursolic acid can enhance inhibiting the entry of the H5N1 virus.

Journal: Bioorganic & medicinal chemistry letters

Published: May 31, 2019

Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.

Structure-based design and structure-activity relationships of 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: January 07, 2018

Design, Synthesis and Structure-Activity Relationship of Novel Aphicidal Mezzettiaside-Type Oligorhamnosides and Their Analogues.

Design, Synthesis and Structure-Activity Relationship of Novel Aphicidal Mezzettiaside-Type Oligorhamnosides and Their Analogues.

Journal: Molecules (Basel, Switzerland)

Published: November 21, 2017

Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.

Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: June 26, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026